Selegiline Transdermal System: In the Treatment of Major Depressive Disorder: A Viewpoint by J. Alexander Bodkin

ISSN： 0012-6667

Source： Drugs, Vol.67, Iss.2, 2007-01, pp. : 266-267

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Selegiline Transdermal System: In the Treatment of Major Depressive Disorder

By Frampton James E. Plosker Greg L.

Drugs, Vol. 67, Iss. 2, 2007-01 ,pp. : 257-265

Adis International

Access to resources Recommend Favorite

Selegiline Transdermal System in Major Depressive Disorder: Profile Report

By Frampton James E. Plosker Greg L.

CNS Drugs, Vol. 21, Iss. 6, 2007-01 ,pp. : 521-524

Adis International

Access to resources Recommend Favorite

Agomelatine for the treatment of major depressive disorder

By Carney Regina M Shelton Richard C

Expert Opinion on Pharmacotherapy, Vol. 12, Iss. 15, 2011-10 ,pp. : 2411-2419

Informa Healthcare

Access to resources Recommend Favorite

Escitalopram: In the Treatment of Major Depressive Disorder in Adolescent Patients

By Yang Lily P.H. Scott Lesley J.

Pediatric Drugs, Vol. 12, Iss. 3, 2010-06 ,pp. : 155-163

Adis International

Access to resources Recommend Favorite

Escitalopram for the treatment of major depressive disorder in youth

By Ahn Joon-Ho Patkar Ashwin A

Expert Opinion on Pharmacotherapy, Vol. 12, Iss. 14, 2011-10 ,pp. : 2235-2244

Informa Healthcare

Access to resources Recommend Favorite